SEALSQ Corp (NASDAQ: LAES), ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, ...

A study published in The Lancet showed a significant survival benefit for patients with oropharyngeal cancers who were ...

Nearly a quarter of provider organizations now use specialized AI tools, a sevenfold increase since 2024 and tenfold since ...

Around 9,300 children across the Gaza Strip were identified as acutely malnourished in October. Deaths relating to starvation ...

A new Tufts study found that Medicare price negotiations on biologics with imminent biosimilars could lead to near-term savings, but greater savings are likely from biosimilar competition.

Possession or use of controlled medicines without a valid prescription will be treated as a serious criminal offences ...

Highlights: FDA has completed their review of the Neurizon NUZ-001 regimen to the HEALEY ALS Platform Trial Master Protocol ; This marks the official entry of NUZ-001 as Regimen I ...

Flitto (CEO Simon Lee), a global AI language data & real-time translation solution company, is strengthening its foothold in the U.S. East Coast market and expanding its North American business in ...

Aceh. The National Nutrition Agency (BGN) continues to roll out nutritious meals to evacuees in the flood-hit West Sumatra, ...

Dr. Samuel Kenneth Adolphus Bernard CRABBE In Article 1, we explored how global equity crowdfunding evolved into a ...

ESTERO, FL / ACCESS Newswire / December 4, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology, ...

Health professionals have emphasised the need for a systematic approach to understanding and addressing barriers to effective ...